The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Collagenase Option for Reduction of Dupuytren's Contracture in Japan
Official Title: Phase III Study of AK160 in Patients With Dupuytren's Contracture
Study ID: NCT01588353
Brief Summary: To investigate the efficacy and safety of AK160 in patients with Dupuytren's Contracture. To determine plasma concentration after the first injection of AK160 in patients with Dupuytren's Contracture.
Detailed Description:
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
, Aichi, , Japan
, Aomori, , Japan
, Chiba, , Japan
, Fukuoka, , Japan
, Hiroshima, , Japan
, Hokkaido, , Japan
, Ishikawa, , Japan
, Iwate, , Japan
, Kanagawa, , Japan
, Kumamoto, , Japan
, Kyoto, , Japan
, Mie, , Japan
, Nagano, , Japan
, Nagasaki, , Japan
, Niigata, , Japan
, Okayama, , Japan
, Osaka, , Japan
, Tokushima, , Japan
, Tokyo, , Japan
, Yamaguchi, , Japan